W

Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak

Business Management
Share
Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak

While Ozempic maker Novo Nordisk has fallen on tough times, Wall Street analysts have still been reluctant to advise investors to sell the stock, until Deutsche Bank lowered the boom on Thursday.

Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak

Source：MarketWatch

Disclaimer：Please read market information rationally and stay aware of investment risks. All content on this site is for informational purposes only and does not constitute investment advice.

Related Reading

Strategy skips Bitcoin buy to repurchase $176M of STRC preferred shares

Strategy repurchased $176 million worth of its STRC preferred stock and doubled the size of its digital securities repurchase program to $2 billion, while…

Mexico quadruple homicide tied to alleged Bitcoin robbery attempt

Two suspects face a Wednesday hearing over four killings allegedly linked to a crypto wallet believed to hold millions of dollars in Bitcoin.…

Why the yen’s rise to a six-month high could go further

A carry trade unwind, a selldown in U.S. Treasury holdings and supportive fundamentals have all been cited Source：MarketWatch

Circle to acquire Tazapay to expand USDC cross-border payments

Tazapay processes $25 billion in annualized volume and offers payout rails across 100plus markets, extending Circle’s USDC payments reach. Source：Cointelegraph

Source：https://www.marketwatch.com/story/ozempic-maker-novo-nordisk-downgraded-to-sell-after-70-stock-price-dive-from-peak-90193914